Wolverine Asset Management’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-418
| Closed | -$305K | – | 1409 |
|
|
2023
Q1 | $305K | Buy |
418
+34
| +9% | +$24.8K | ﹤0.01% | 696 |
|
|
2022
Q4 | $278K | Sell |
384
-410
| -52% | -$296K | ﹤0.01% | 784 |
|
|
2022
Q3 | $563K | Buy |
794
+37
| +5% | +$26.2K | 0.01% | 748 |
|
|
2022
Q2 | $534K | Sell |
757
-31
| -4% | -$21.9K | 0.01% | 770 |
|
|
2022
Q1 | $555K | Buy |
788
+775
| +5,962% | +$546K | 0.01% | 766 |
|
|
2021
Q4 | $8K | Sell |
13
-2,439
| -99% | -$1.5M | ﹤0.01% | 1546 |
|
|
2021
Q3 | $1.72M | Hold |
2,452
| – | – | 0.01% | 384 |
|
|
2021
Q2 | $1.7M | Buy |
+2,452
| New | +$1.7M | 0.01% | 345 |
|